DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Laszlo GS, Alonzo TA, Gudgeon CJ. , et al.
High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
J Hematol Oncol 2015;
8: 115
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.